Novo Nordisk Algeria belongs to International Operations, Business Area Africa (IO-BAAF).
Novo Nordisk is present in Algeria since 1992 and the company, headquartered in Algiers, employs more than 400 employees, hundred and fifty (150) of them working in the tablets factory situated in Tizi Ouzou, and forty (40) working in the Supply Chain organization, located in Algiers, Constantine and Oran and servicing, directly and indirectly, the whole Algeria territory (2.3 million km2).
It is Novo Nordisk Algeria Ambition to always be competitive, on the edge of innovation, engaged & committed, to improve lives’ of people with Non Communicable Chronic Diseases.
Since 1992, Novo Nordisk Algeria has built and consolidated its leadership in all therapeutic area it is operating in: Diabetes, Hemophilia and Growth Disorders, working in line with the Triple Bottom Line responsibility of the company ( social , environmental and financial ) and focusing and consolidating activities around the patients.
Today, in Novo Nordisk Algeria, due to the commitment of our employees, the quality of our products, and the broad range and varieties of our sustainable activities including production, distribution, clinical trials, and public affairs, on top of the classical yet effective sales and marketing operations, we are, and aim at resting, an undisputable leader and preferred partner in Algeria